Trial Profile
A Repeated Dose Study of JNS010 (Paliperidone Palmitate) in Patients With Schizophrenia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizophrenia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Janssen Pharmaceutical KK
- 29 May 2012 New trial record